Less than a month after cannabis producer CannTrust Holdings Inc CTST was issued a noncompliance report from Canadian regulators for growing marijuana on unlicensed property, CannTrust investors received some more bad news on Friday when the company said its auditor has withdrawn all its recent financial statements.
Last week, CannTrust said its financial statements from 2018 and 2019 may need to be restated due to issues related to unlicensed operations. On Friday, CannTrust auditor KPMG withdrew the reports in question after CannTrust shared “newly uncovered information” with the auditors.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
Why It’s Important
CannTrust investors must now interpret the vague language of the press release to try to get a grip on just how much of a financial impact the latest news will have on the company.
KPMG said it will remain on board as CannTrust’s auditor, but the company has said it may miss the filing deadline for its second-quarter earnings report. CannTrust also said KPMG was unaware of the licensing problems when it originally completed the reports and relied on representations made by individuals who are no longer employed by CannTrust.
“We will continue cooperating with our auditor and regulators, and take whatever steps are necessary to restore full trust in the Company's regulatory compliance,” CannTrust CEO Robert Marcovitch said in a statement.
What’s Next
CannTrust investors and cannabis investors in general are eager to put the licensing issue behind them. Canadian regulator Health Canada is conducting an ongoing investigation into CannTrust’s situation. Investors will be watching to see what type of penalties and/or fines Health Canada will ultimately impose on CannTrust and whether or not the company’s license is suspended or revoked.
CannTrust's stock traded lower by 4% to $2.16 at time of publication.
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more!
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.